Showing results (31-40 of 305) with videos related to
Sort By:
Pageof 31
Seminars in Cutaneous Medicine and Surgery|April 4, 2018
Treating to Target-A Realistic Goal in Psoriasis?Kenneth B Gordon, April W Armstrong, M Alan Menter, et al.Archives of Dermatological Research|January 18, 2012
Exploring the role of prolactin in psoriasisEwan A Langan, Christopher E M Griffiths, Ralf PausInternational Journal of Molecular Sciences|January 21, 2023
Exploring Mast Cell-CD8 T Cell Interactions in Inflammatory Skin DiseasesYiqiao Chen, Christopher E M Griffiths, Silvia Bulfone-PausJournal of the American Academy of Dermatology|April 19, 2014
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous diseaseAntoinette Day, Amanda K Abramson, Mahir Patel, et al.Plastic and Reconstructive Surgery|September 16, 2003
Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar linesJean D Carruthers, Nicolas J Lowe, M Alan Menter, et al.Journal of Drugs in Dermatology : JDD|July 24, 2009
Genomic-driven insights into changes in aging skinMichael K Robinson, Robert L Binder, Christopher E M GriffithsDermatologic Clinics|August 23, 2005
Psychologic factors in psoriasis: consequences, mechanisms, and interventionsDónal G Fortune, Helen L Richards, Christopher E M GriffithsThe Journal of Investigative Dermatology|July 31, 2013
Responsiveness to change and interpretability of the simplified psoriasis indexLeena Chularojanamontri, Christopher E M Griffiths, Robert J G ChalmersArchives of Dermatology|September 19, 2007
Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasisElizabeth M Seston, Darren M Ashcroft, Christopher E M GriffithsAdvances in Therapy|June 12, 2025
Systematic Review of the Use of the WHO-5 Well-Being Index Across Different Disease AreasArnau Domenech, Ismail Kasujee, Volker Koscielny, et al.Pageof 31